J-Pharma Co (TSE:520A) OCF Margin %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:520A J-Pharma Co Ltd TSE:520A
9 GF Score
Price 円290.00
View Full Analysis

What is J-Pharma Co OCF Margin %?

J-Pharma Co TSE:520A -2.36% 9 OCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates TSE:520A with a GF Score™ of 9/100. Among 950 Biotechnology companies, J-Pharma Co ranks worse than 105263.05% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. J-Pharma Co's Cash Flow from Operations for the three months ended in Dec. 2025 was 円0.00 Mil. J-Pharma Co's Revenue for the three months ended in Dec. 2025 was 円0.00 Mil. Therefore, J-Pharma Co's OCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, J-Pharma Co's current OCF Yield % is -31.73%.

The historical rank and industry rank for J-Pharma Co's OCF Margin % or its related term are showing as below:


TSE:520A's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -64.565
* Ranked among companies with meaningful OCF Margin % only.

J-Pharma Co OCF Margin % Related Terms

J-Pharma Co OCF Margin % Historical Data

* Premium members only.

The historical data trend for J-Pharma Co's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

J-Pharma Co OCF Margin % Chart

J-Pharma Co Annual Data
Trend Mar24 Mar25
OCF Margin %
0.00 0.00

J-Pharma Co Quarterly Data
Mar24 Mar25 Dec25
OCF Margin % 0.00 0.00 0.00
TSE:520A
9GF Score
J-Pharma Co Ltd TSE:520A
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

J-Pharma Co OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

J-Pharma Co's OCF Margin for the fiscal year that ended in Mar. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2025 )/Revenue (A: Mar. 2025 )
=-1694.864/0
= %

J-Pharma Co's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
J-Pharma Co (TSE:520A) has a OCF Margin % of 0.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on J-Pharma Co and its competitors. According to the industry distribution chart, J-Pharma Co ranks #999999 out of 950 companies in the Biotechnology industry.
Is J-Pharma Co's OCF Margin % too high?
J-Pharma Co's current OCF Margin % is 0.00%. Based on the distribution chart, J-Pharma Co ranks #999999 out of 950 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, J-Pharma Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does J-Pharma Co's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, J-Pharma Co ranks #999999 out of 950 companies for OCF Margin %. This places J-Pharma Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on J-Pharma Co and its competitors. J-Pharma Co's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is J-Pharma Co stock overvalued right now?
J-Pharma Co (TSE:520A) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. J-Pharma Co's overall GF Score™ is 9/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For J-Pharma Co (TSE:520A), the current OCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

J-Pharma Co Business Description

Address 1-10-11, HamamatsuCho, 8th floor, Minato-Ku, Tokyo, JPN, 105-0013
J-Pharma Co Ltd is engaged in the Drug discovery and development targeting SLC transporters. It is focused on a single segment of the drug discovery business, focusing on R&D and clinical development. The company's two compounds in clinical development are Nanbran Latte (JPH203) and JPH034.
9GF Score

Get the complete analysis for TSE:520A

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円290.00
Price